Physician profile
David Roble
NPI 1639675218
$1,764.22
in general payments reported to CMS, 2019-2025
18 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $377 · 2022: $106 · 2023: $564 · 2024: $250 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,280.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $372.84 | 2022-2025 | |
| Stryker Corporation | $283.24 | 2021-2025 | Citrefix, Augment Injectable |
| Paratek Pharmaceuticals, INC. | $270.65 | 2022-2025 | Nuzyra |
| Organogenesis INC. | $207.85 | 2023-2025 | Puraply, Affinity |
| Kerecis Limited | $129.40 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Royal Biologics, INC. | $124.35 | 2021 | |
| Osteomed LLC | $80.13 | 2021 | |
| Misonix INC | $70.01 | 2021 | |
| Averitas Pharma INC. | $37.82 | 2024-2025 | Qutenza |
| Medtronic, INC. | $33.11 | 2025 | Inceptiv |
| Integra Lifesciences Corporation | $32.92 | 2022 | |
| Convatec INC. | $26.41 | 2023 | |
| Ibsa Pharma INC. | $21.86 | 2023 | Tirosint, Licart |
| Zimvie INC. | $18.77 | 2022 | |
| Smith+Nephew, INC. | $15.77 | 2023 | Regranex, Collagenase Santyl |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $15.26 | 2024 | |
| Mimedx Group, INC. | $13.85 | 2025 | |
| Orthofix Medical, INC. | $9.98 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Roble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.